incannex.com.au (IXHL) Company Sales Volume

The Incannex Healthcare (IXHL) strategy is based on patents and trials of cannabinoid psychedelics for apnea therapy. The company's total sales reflect commercial expansion dynamics, while the 0.00 metric confirms the current level. The development of anxiety and sleep apnea medications in the US provides potential for global growth. The executive team is betting on rigorous scientific verification and the successful completion of clinical stages.

Revenue and Sales Volume: Incannex (IXHL) for 04/28/2023 - 11/13/2026

Analytical breakdowns for Incannex Healthcare

- market value and analyst target forecast:

Market Chart Incannex Corp|IXHL - Price Target Chart

- market capitalization details:

Market Capitalization Incannex Healthcare Limited|IXHL - Enterprise Value

- issuer book value statistics:

Accounting Value per Share Incannex Healthcare|IXHL - Book Capitalization|Market Capitalization to Book Value Ratio incannex.com.au|IXHL - Aggregate Company Assets

- debt and solvency information:

Debt to Equity Ratio Incannex Healthcare|IXHL - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Incannex Healthcare Ltd|IXHL - Company Aggregate Debts|Debts to Book Value Incannex Healthcare Limited|IXHL - Company Long-Term Liabilities|Company Short-Term Indebtedness Incannex Healthcare|Intermediate Coverage Ratio incannex.com.au

- company profitability and valuation multiples indicators:

IXHL - Net Profit|Expected Net Income Incannex Healthcare|IXHL - P/E Multiple|Projected Price to Earnings Ratio incannex.com.au|IXHL - PEG Multiple|EV/EBITDA Multiple Incannex Healthcare Limited|IXHL - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Incannex Healthcare|IXHL - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months incannex.com.au|IXHL - Earnings growth in current year|Expected earnings per share trend next year Incannex Healthcare

- company sales and revenue statistics:

IXHL - Revenue and Sales Volume|Company Future Sales Volume Incannex Corp|IXHL - P/S Multiple|Forward P/S Multiple Incannex Healthcare Limited

Summary company analysis:IXHL (Incannex Corp)

Incannex Healthcare operates in the high-risk biopharmaceutical development sector. By analyzing the company's sales time series, an investor assesses the actual liquidity inflow, separating market noise from fundamental growth. This metric captures actual revenue, serving as an objective measure of the business's operational viability across different cycle phases. The absence of commercial products makes this indicator a reflection of the issuer's dependence on external financing and grants.

Competing companies